Evonik Industries (EVK) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
31 Jan, 2026Opening remarks and agenda
AGM opened by the chairman, held virtually in accordance with legal statutes, with all formalities and technical instructions provided for participation and voting.
No additional shareholder motions or proposals for election were submitted; agenda items and procedures were clearly outlined.
Board and executive committee updates
Supervisory board reviewed and approved financial statements and profit appropriation proposals, with no objections raised.
Supervisory board activities included diligent oversight, strategic advice, and regular dialogue with the management board.
Committee structure was updated, including renaming to Investment and Sustainability Committee, and new employee representatives introduced.
Three new employee representatives joined the supervisory board, each presenting their backgrounds and commitment to the company's future.
Financial performance review
2023 marked by weak demand, inflation, and geopolitical crises, leading to a profit warning and cost-saving measures.
Group sales fell 17% to EUR 15.3 billion; adjusted EBITDA was EUR 1.66 billion, within the target range.
Net income was negative due to impairments and structural charges, but adjusted earnings per share were EUR 0.79.
Free cash flow reached EUR 801 million, exceeding the previous year and supporting dividend stability.
Latest events from Evonik Industries
- Achieved FY 2025 guidance with robust cash flow and a new dividend policy for future flexibility.EVK
Investor presentation4 Mar 2026 - Sustainability drives growth, innovation, and emissions reduction, targeting >50% sales from green solutions.EVK
Sustainability presentation4 Mar 2026 - 2025 guidance met with €1,874m EBITDA; stable 2026 outlook and new dividend policy affirmed.EVK
Q4 20254 Mar 2026 - FY 2025 guidance met with strong cash flow; stable 2026 outlook and new dividend policy set.EVK
Q4 2025 TU7 Feb 2026 - Q2 2024 EBITDA up 28% year-over-year; FY guidance raised to €1.9–2.2bn.EVK
Q2 20242 Feb 2026 - Q3 adjusted EBITDA up 19%, margin at 15%, and 2024 outlook confirmed.EVK
Q3 202416 Jan 2026 - New flexible epoxy curing agents offer high elongation, toughness, and eco-friendly features.EVK
Status Update8 Jan 2026 - 25% EBITDA growth, strong FCF, and secured green bond drive optimism for 2025.EVK
Q4 202421 Dec 2025 - €1bn EBITDA and 11% ROCE targeted by 2027 through innovation, optimization, and sustainability.EVK
CMD 202520 Nov 2025